181 related articles for article (PubMed ID: 11490031)
1. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes.
Johnson EA; Silveira P; Chapman HD; Leiter EH; Serreze DV
J Immunol; 2001 Aug; 167(4):2404-10. PubMed ID: 11490031
[TBL] [Abstract][Full Text] [Related]
2. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
[TBL] [Abstract][Full Text] [Related]
3. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
4. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
[TBL] [Abstract][Full Text] [Related]
5. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
6. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
7. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
[TBL] [Abstract][Full Text] [Related]
8. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
9. Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells.
Pilström B; Böhme J
Immunology; 1997 Apr; 90(4):483-8. PubMed ID: 9176099
[TBL] [Abstract][Full Text] [Related]
10. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
11. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.
La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N
J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117
[TBL] [Abstract][Full Text] [Related]
12. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.
Serreze DV; Chapman HD; Varnum DS; Hanson MS; Reifsnyder PC; Richard SD; Fleming SA; Leiter EH; Shultz LD
J Exp Med; 1996 Nov; 184(5):2049-53. PubMed ID: 8920894
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.
Serreze DV; Fleming SA; Chapman HD; Richard SD; Leiter EH; Tisch RM
J Immunol; 1998 Oct; 161(8):3912-8. PubMed ID: 9780157
[TBL] [Abstract][Full Text] [Related]
15. Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background.
Koarada S; Wu Y; Olshansky G; Ridgway WM
J Immunol; 2002 Dec; 169(11):6580-7. PubMed ID: 12444170
[TBL] [Abstract][Full Text] [Related]
16. Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin.
Serreze DV; Bridgett M; Chapman HD; Chen E; Richard SD; Leiter EH
J Immunol; 1998 Feb; 160(3):1472-8. PubMed ID: 9570569
[TBL] [Abstract][Full Text] [Related]
17. Effect of X- and Y-box deletions on the development of diabetes in H-2Ealpha-chain transgenic nonobese diabetic mice.
O'Shea H; Yousaf N; Altmann D; Fehervari Z; Tonks P; Hetherington C; Harach S; Bland C; Cooke A; Lund T
Scand J Immunol; 2006 Jan; 63(1):17-25. PubMed ID: 16398697
[TBL] [Abstract][Full Text] [Related]
18. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
[TBL] [Abstract][Full Text] [Related]
20. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
Serreze DV; Gaskins HR; Leiter EH
J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
